Valuation : Treace Medical Concepts, Inc.

Market Cap 302M 261M 244M 223M 420M 28.9B 421M 2.9B 1.13B 14.59B 1.14B 1.11B 48.38B P/E 2026 *
-5.47x
P/E 2027 * -6x
Enterprise Value 348M 300M 281M 257M 484M 33.27B 485M 3.34B 1.3B 16.79B 1.31B 1.28B 55.68B EV / Sales 2026 *
1.68x
EV / Sales 2027 * 1.75x
Free-Float
74.43%
Yield 2026 *
-
Yield 2027 * -
1 day+1.09%
1 week+7.14%
Current month+7.89%
1 month+6.16%
3 months+34.39%
6 months+180.12%
Current year+89.80%
1 week 4.4
Extreme 4.405
5.01
1 month 4.25
Extreme 4.25
5.2
Current year 1.17
Extreme 1.17
5.2
1 year 1.17
Extreme 1.17
7.63
3 years 1.17
Extreme 1.17
15.98
5 years 1.17
Extreme 1.17
31.02
10 years 1.17
Extreme 1.17
37.17
Manager TitleAgeSince
Chief Executive Officer 54 2013-06-30
Director of Finance/CFO 56 2020-08-31
Chief Tech/Sci/R&D Officer - 2022-02-28
Director TitleAgeSince
Chairman 54 2025-05-19
Director/Board Member 65 2020-11-19
Director/Board Member 68 2020-11-19
Date Insider Type Main position Quantity % Market Cap.
8/24/26 Buy

Chief Executive Officer

11,000 0.0170%
8/9/26 Tax

Chief Financial Officer

-37,102 0.0572%
8/9/26 Tax

Responsable ventes & marketing

-9,814 0.0151%
Change 5-day change 1-year change 3-year change Capi.($)
+1.09%+7.14%-36.65%-71.28% 302M
+0.21%-1.08%+17.99%+21.88% 12.67B
+0.81%+1.27%+19.40%+30.42% 7.03B
-0.66%-6.57%+44.73%+27.54% 6.32B
+3.02%-1.71% - - 5.64B
-0.97%-5.83%-12.74%+47.38% 5.14B
-0.30%+3.22%-29.78%-23.08% 3.89B
-0.94%+4.21%+44.53%-18.74% 2.08B
+0.67%+6.19%-14.16%+132.56% 1.77B
-0.16%+2.09%+52.57%-13.49% 1.65B
Average +0.29%+1.22%+9.54%+14.80% 4.65B
Weighted average by Cap. +0.31%-0.80%+14.90%+23.77%

Financials

2026 *2027 *
Net sales 207M 179M 168M 153M 288M 19.83B 289M 1.99B 776M 10.01B 779M 762M 33.19B 222M 191M 179M 164M 308M 21.19B 309M 2.13B 829M 10.7B 833M 814M 35.47B
Net income -55.26M -47.62M -44.65M -40.76M -76.78M -5.28B -77.03M -530M -207M -2.67B -207M -203M -8.84B -51.01M -43.96M -41.21M -37.62M -70.87M -4.88B -71.1M -489M -191M -2.46B -192M -187M -8.16B
Net Debt 45.67M 39.35M 36.9M 33.68M 63.45M 4.36B 63.65M 438M 171M 2.2B 171M 168M 7.31B 86.44M 74.48M 69.84M 63.75M 120M 8.26B 120M 829M 323M 4.17B 325M 317M 13.83B
Logo Treace Medical Concepts, Inc.
Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.
Employees
450
Date Price Change Volume
26-08-28 US$4.650 +1.09% 237,099
26-08-27 US$4.600 -2.54% 226,045
26-08-26 US$4.720 -1.87% 217,751
26-08-25 US$4.810 +10.07% 595,110
26-08-24 US$4.370 +0.69% 348,149
Trader
Investor
-
Global
-
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
4.650USD
Average target price
5.500USD
Spread / Average Target
+18.28%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TMCI Stock